Efficacy and Safety of Robotic-assisted Bronchoscopy Combined With the ICNVA Strategy in Biopsy of Peripheral Pulmonary Nodules

Efficacy and Safety of Robotic-assisted Bronchoscopy Combined With the ICNVA Strategy in Biopsy of Peripheral Pulmonary Nodules: A Prospective, Single-center, Single-arm Study

To assess the efficacy and safety of robotic-assisted bronchoscopy system (bronchial navigation and positioning device) combined with ICNVA strategy for peripheral pulmonary nodule biopsy through a prospective, single-center, single-arm study.

Inclusion Criteria:

1. Age ≥18 years old, and ≤75 years old, male or female;
2. Patients with peripheral lung lesions found by chest CT, whose diameter ≥ 6mm and < 3cm, who plan to undergo robotic-assisted bronchoscopic for pulmonary biopsy;
3. The patient voluntarily undergo bronchoscopy and meet the requirements for bronchoscopy;
4. Patients can understand the purpose of the trial, have good compliance with the examination and follow-up, voluntarily participate in the clinical trial and sign the informed consent.

Exclusion Criteria:

1. Patients with cardiovascular diseases, such as blood pressure instability, myocardial infarction or arrhythmia;
2. Patients with massive hemoptysis within two weeks;
3. Patients with severe pneumothorax and rib fracture;
4. Patients with serious infectious diseases, such as tuberculosis or AIDS;
5. Patients with severe abdominal aortic aneurysm or thoracic aortic aneurysm;
6. Participants who have participated in or are participating in drug clinical trials within 3 months before screening, or have participated in other medical device clinical trials within 30 days;
7. Those who were not considered suitable for inclusion by the researchers.